Ara
Toplam kayıt 471, listelenen: 291-300
Association of Fetuin-A with Carotid Intima-Media Thickness and Vascular Diseases
(Springer, 2016)
Fetuin-A, also known as alpha 2-Heremans-Schmid glycoprotein (AHSG), is a member of the cystatin superfamily of cysteine protease inhibitors and has different functions in human physiology and pathophysiology. Most studies ...
Re: Heart rate recovery and methodological issues
(AVES Ibrahim Kara, 2015)
[No abstract available]
Supraorbital and infraorbital nerve blockade in migraine patients: results of 6-month clinical follow-up
(Verduci Publisher, 2013)
BACKGROUND: Nerve blockades are used for the treatment of acute migraine episodes in emergency room conditions and beneficial results are obtained from this clinical use. Although this is the case, there are limited numbers ...
The importance of examining antinuclear antibody (ANA) in neurological diseases
(2013)
Objective: In neurological clinical practice screening test for ANA (Anti-nuclear antibody) is helpful in the diagnosis of autoimmune diseases which have neurological involvement. ANA investigation tests might be positive ...
After stroke: Guidelines of Turkish Society of cerebrovascular diseases 2015
(Turkish Society of Cerebrovascular Diseases, 2015)
In this section, recommendation of recent management approaches about post-stroke complications such as sensorymotor function impairment, drops, epilepsy, depression and dementia will be offered.
Bortezomib-induced peripheral neuropathy and neuronopathy in patients with multiple myeloma
(Springer Heidelberg, 2013)
[No Abstract Available]
Self-management and coping strategies in patients with multiple sclerosis - a multicenter-prospective study
(Sage Publications Ltd, 2019)
[No Abstract Available]
Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study
(Amer Soc Hematology, 2019)
[No Abstract Available]
GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.
(Amer Soc Clinical Oncology, 2019)
[No Abstract Available]